These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11173689)

  • 21. Pancytopenia after treatment of keratoacanthoma by single lesional methotrexate infiltration.
    Goebeler M; Lurz C; Kolve-Goebeler ME; Bröcker EB
    Arch Dermatol; 2001 Aug; 137(8):1104-5. PubMed ID: 11493112
    [No Abstract]   [Full Text] [Related]  

  • 22. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
    Parker CM; Hanke CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized eruptive keratoacanthoma: a diagnostic and therapeutic challenge.
    Nofal A; Assaf M; Ghonemy S; Nofal E; Yosef A
    Int J Dermatol; 2015 Feb; 54(2):160-7. PubMed ID: 25070745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of multiple keratoacanthoma centrifugum marginatum.
    Mangas C; Bielsa I; Ribera M; Fernández-Figueras MT; Ferrándiz C
    Dermatol Surg; 2004 May; 30(5):803-6. PubMed ID: 15099330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effective treatment of recurrent keratoacanthoma using methotrexate].
    Schoon-Blaauw GH; Berretty PJ; Ideler AH; Tan-Go I
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):410-3. PubMed ID: 8127383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional methotrexate for keratoacanthomas: A retrospective cohort study.
    Smith C; Srivastava D; Nijhawan RI
    J Am Acad Dermatol; 2020 Sep; 83(3):904-905. PubMed ID: 32268170
    [No Abstract]   [Full Text] [Related]  

  • 27. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge.
    Divers AK; Correale D; Lee JB
    Cutis; 2004 Apr; 73(4):257-62. PubMed ID: 15134326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
    Sayan A; Taibjee S; Ilankovan V
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of Favre-Racouchot disease with 0.05% tazarotene gel.
    Rallis E; Karanikola E; Verros C
    Arch Dermatol; 2007 Jun; 143(6):810-2. PubMed ID: 17576962
    [No Abstract]   [Full Text] [Related]  

  • 31. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy.
    Sanders S; Busam KJ; Halpern AC; Nehal KS
    Dermatol Surg; 2002 Oct; 28(10):954-8. PubMed ID: 12410683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate.
    Panther D; Nino T; Macknet KD; Macknet C
    Dermatol Surg; 2015 Jan; 41(1):172-5. PubMed ID: 25533164
    [No Abstract]   [Full Text] [Related]  

  • 33. Giant keratoacanthoma-type low-grade squamous cell carcinoma of the upper lip: Response to intralesional interferon alpha-2B.
    Anadolu R; Akay BN; Bodamyali P; Akyol A
    J Dermatolog Treat; 2011 Aug; 22(4):239-40. PubMed ID: 20666675
    [No Abstract]   [Full Text] [Related]  

  • 34. Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil.
    Yuge S; Godoy DA; Melo MC; Sousa DS; Soares CT
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S218-9. PubMed ID: 16631944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralesional methotrexate for keratoacanthoma of the nose.
    Cohen PR; Schulze KE; Teller CF; Nelson BR
    Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lip ulceration disclosing systemic lupus erythematosus: 3 cases].
    Bourgault I; Zeller J; Roujeau JC; Poli F; Revuz J
    Ann Dermatol Venereol; 1989; 116(11):822-4. PubMed ID: 2619176
    [No Abstract]   [Full Text] [Related]  

  • 37. Guess what! Keratoacanthoma treated with intralesional bleomycin.
    Andreassi A; Pianigiani E; Taddeucci P; Lorenzini G; Fimiani M; Biagioli M
    Eur J Dermatol; 1999; 9(5):403-5. PubMed ID: 10484668
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic problems in rosacea and perioral dermatitis].
    Janicka D; Raszeja-Kotelba B; Stepień B
    Pol Tyg Lek; 1981 Jan; 36(2):61-2. PubMed ID: 6113580
    [No Abstract]   [Full Text] [Related]  

  • 39. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
    Spieth K; Gille J; Kaufmann R
    Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancytopenia after a single intradermal infiltration of methotrexate.
    Cohen PR; Schulze KE; Nelson BR
    J Drugs Dermatol; 2005; 4(5):648-51. PubMed ID: 16167425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.